Lecture

Social Innovation Strategies

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

In course

MGT-408: Transitions, sustainability and technology policy

This course addresses the issue of designing innovation strategies and technology policies to support transitions towards sustainable development goals. ...

Description

This lecture discusses the concept of social innovation, focusing on the need for innovations to address severe market failures and create social value. It explores examples such as new vaccines for global markets and the role of advanced market commitments in fixing market spillovers. The instructor presents cases where social innovation is a necessity due to high fixed costs and the inability of private innovators to capture value. The lecture also delves into the importance of evaluating social innovations and the impact of scale in achieving large-scale transformational benefits for society.

Instructor

Dominique Foray

1 - Current occupations and activities I am Full Professor at the Ecole Polytechnique Fédérale de Lausanne (EPFL) and hold the Chair of Economics and Management of Innovation (CEMI). I am a member of the Swiss Council for Science (SWR); chairman of the Advisory Board of the Swiss Economic Research Institute (KOF); and a foreign member of the Center of Capitalism and Society (Columbia University, New York). From 2007 to 2015, I served as a member of the Swiss National Research Council (Division IV - Large Scale Programs) From 2013 to 2016, I was a member of the Expert Commission for Research and Innovation of Germany (E-FI) and a member of the Expert Group for the National Report on Research and Innovation (SBFI, Switzerland). From 2008 to 2011, I served as chairman of the expert group Knowledge for Growth; a group of prominent economists created to advise Commissioner J. Potocnik (European Commission, DG research). This is during this service as member of this Group that I developed the concept of smart specialisation (together with P.A.David and B.Hall) that is now a key policy mechanism of the EU (cohesion policy). My expertise includes the economics of innovation and knowledge and the economic policy implications of the new knowledge-based economy. I have presented many opening speeches and key note address in academic and policy conferences on these topics. I have written numerous academic papers as well as two books and have edited several books and special issues in these fields. Among these books,I like to highlight : Technology and the Wealth of Nations (Pinter, 1992) ed.with C.Freeman; Unemployment and Growth in the Knowledge-based Economy (OECD, 1996), ed. with B.A.Lundvall; Knowledge economies and societies (a special issue of the International Social Science Journal, Basil Blackwell, 2002, with editions in French, Spanish, Chinese, Arabs, Russian); The Economics of knowledge (MIT press, 2004, paperback in 2006) with editions in France, Italy, Korea, China, Greece, Syria and Algeria The New Economics of Technology Policy(Edward Elgar)2009, ed.; . Smart specialisation : opportunities and challenges for regional innovation policy(Routledge, 2015) Since 2017, I regularly contribute to the Swiss Science Council blog: https://blog.wissenschaftsrat.ch/ 2 Education, previous appointments and academic positions - I received my Ph.D. in economics in 1984 and my "habilitation à diriger des recherches" in 1992 from the University Lumière of Lyon. - In 1985, I joined the Centre National de la Recherche Scientifique (CNRS) as a Research Fellow in economics. - In 1990, I joined the Ecole Centrale de Paris as professor of economics, and taught in the program ingénieur économiste. - In 1993, I was nominated as Research Director at CNRS and joined the Institut pour le Management de la Recherche et de l'Innovation (IMRI) of the University of Paris-Dauphine. - In 2001-2004, I worked as a Principal Analyst at the Center for Education, Research and Innovation of OECD (Paris). - I joined the EPFL as Professeur Ordinaire in 2004. 3 - Honours and awards Best young economist award - City of Lyon (France)1986 Outstanding research in 1995 (médaille du CNRS)(France) Futuris award in 2012 for his work on smart specialisation Best paper award, EJIM, 2014 Doctor Honoris Causa, University of Cluj Napoca, 2017 I was also elected as Research Fellow at ICER (International Center for Economic Research) in Turin, at the Wissenschaftskolleg in Berlin and at IIASA in Laxenburg; and I was Invited Professor at the Universities of Santiago de Compostela, Torino and Padova. 4 - Consulting activities I have done consulting work for the UNESCO, the OECD, WIPO, UNCTAD, UN/ECE, the European Commission, the Swiss Government and other public organisations. I am currently strongly involved into the "smart specialisation" debate in Europe, giving talks and providing advices in many countries and regions in Europe.

Official source

Related concepts (32)

Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified.

MRNA vaccine

An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. The vaccine delivers molecules of antigen-encoding mRNA into immune cells, which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen (such as a virus) or by a cancer cell. These protein molecules stimulate an adaptive immune response that teaches the body to identify and destroy the corresponding pathogen or cancer cells.

Attenuated vaccine

An attenuated vaccine (or a live attenuated vaccine, LAV) is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine). Attenuated vaccines stimulate a strong and effective immune response that is long-lasting. In comparison to inactivated vaccines, attenuated vaccines produce a stronger and more durable immune response with a quick immunity onset.

Innovation

Innovation is the practical implementation of ideas that result in the introduction of new goods or services or improvement in offering goods or services. ISO TC 279 in the standard ISO 56000:2020 defines innovation as "a new or changed entity realizing or redistributing value". Others have different definitions; a common element in the definitions is a focus on newness, improvement, and spread of ideas or technologies.

Polio vaccine

Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018. The inactivated polio vaccines are very safe.

Related lectures (64)

Innovation Fundamentals

Delves into the economic fundamentals of innovation, exploring historical context, entrepreneurial risk, societal challenges, and the role of private entrepreneurs.

Design of Immunogenic Vaccines

Explores the design of immunogenic vaccines, boosting immune response through various methods, and addressing challenges in vaccine development.

Innovation Taxonomies: Value Generation & Distribution

Discusses innovation taxonomies, value generation, distribution, and the concept of soft innovation in various industries.

Economics of Crisis Innovation

Explores crisis innovation, comparing the rapid innovation during the COVID crisis to other challenges like the climate crisis, emphasizing the essential framework provided by Dick Nelson.

Innovation Strategies